Nicole M.F. Van Gerven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicole M.F. Van Gerven has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Annemiek A. Van der Eijk
Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands
1 shared publicationBirgit I. Witte
Department of Epidemiology and Biostatistics, VU University Medical Centre,Amsterdam, The Netherlands
1 shared publicationCarin M.J. Van Nieuwkerk
Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
1 shared publicationChris J.J. Mulder
Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
1 shared publicationGerd Bouma
Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
1 shared publicationHans L. Zaaijer
Department of Blood-Borne Infections, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 March 2016
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 25 (1) , 9-13
Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands
Background & Aims: In recent years chronic courses of hepatitis E virus (HEV) infection have been described in immunosuppressed individuals. This may implicate a potential role for HEV in the development of autoimmune diseases, including autoimmune hepatitis (AIH). Here we investigated the prevalence of HEV-antibodies in AIH patients in an endemic Central European country. Methods: HEV-specific immunoglobulin G (IgG) and HEV RNA were determined in 354 and 377 AIH patients, respectively. Clinical characteristics and disease outcome parameters were retrospectively collected. Results: No HEV viraemic patients were identified in this cohort. A total of 106 AIH patients (29.9%) tested positive for anti-HEV IgG, and this figure was slightly higher compared to the prevalence in a reference cohort including 5,329 healthy Dutch blood donors (26.7%; P>0.05). Conclusion: This is the largest study on the association between HEV infection and AIH. Apparently silent HEV infection is present in a significant proportion of AIH patients, yet appears not to have significant clinical repercussions in this immune compromised group of patients. Nevertheless, since acute hepatitis E may present with histological and biochemical features of AIH, the possibility of a (concomitant) HEV infection should be considered in this category of patients.Abbreviations: AIH: autoimmune hepatitis; ALT: alanine aminotransferase; SMA: anti smooth muscle antibodies; ANA: antinuclear antibodies; PBC: primary biliary cirrhosis; AMA: anti mitochondrial antibodies; PSC: primary sclerosing cholangitis.
- 1 March 2016
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 25 (1) , 9-13
Open AccessSeroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands
Background & Aims: In recent years chronic courses of hepatitis E virus (HEV) infection have been described in immunosuppressed individuals. This may implicate a potential role for HEV in the development of autoimmune diseases, including autoimmune hepatitis (AIH). Here we investigated the prevalence of HEV-antibodies in AIH patients in an endemic Central European country. Methods: HEV-specific immunoglobulin G (IgG) and HEV RNA were determined in 354 and 377 AIH patients, respectively. Clinical characteristics and disease outcome parameters were retrospectively collected. Results: No HEV viraemic patients were identified in this cohort. A total of 106 AIH patients (29.9%) tested positive for anti-HEV IgG, and this figure was slightly higher compared to the prevalence in a reference cohort including 5,329 healthy Dutch blood donors (26.7%; P>0.05). Conclusion: This is the largest study on the association between HEV infection and AIH. Apparently silent HEV infection is present in a significant proportion of AIH patients, yet appears not to have significant clinical repercussions in this immune compromised group of patients. Nevertheless, since acute hepatitis E may present with histological and biochemical features of AIH, the possibility of a (concomitant) HEV infection should be considered in this category of patients.Abbreviations: AIH: autoimmune hepatitis; ALT: alanine aminotransferase; SMA: anti smooth muscle antibodies; ANA: antinuclear antibodies; PBC: primary biliary cirrhosis; AMA: anti mitochondrial antibodies; PSC: primary sclerosing cholangitis.